AbbVie scores blockbuster approval for RA med Rinvoq, its crucial Humira follow-up
admin 16th August 2019 Uncategorised 0The second of AbbVie’s highly anticipated 2019 blockbuster candidates is here. Friday, the FDA greenlighted Rinvoq, a rheumatoid arthritis med meant to succeed best-selling Humira as copycats bite into its sales. The new product should be available in the U.S. by late August, AbbVie said.
More: AbbVie scores blockbuster approval for RA med Rinvoq, its crucial Humira follow-up
Source: fierce